Tag: substandard drugs
-

The Regulatory Gap in the Indian Pharmaceutical Sector: Concerns Over Quality and Oversight
The Indian pharmaceutical sector is a critical part of the global healthcare industry, but concerns over the quality and safety of drugs produced in the country have raised alarm bells among regulatory bodies and patient advocacy groups. While the US FDA is responsible for monitoring drugs sold in the US market, its oversight does not…